NL8603132A - Monoklonale antilichamen kruis-reactief en kruis-beschermend tegen p. aeruginosa serotypen. - Google Patents

Monoklonale antilichamen kruis-reactief en kruis-beschermend tegen p. aeruginosa serotypen. Download PDF

Info

Publication number
NL8603132A
NL8603132A NL8603132A NL8603132A NL8603132A NL 8603132 A NL8603132 A NL 8603132A NL 8603132 A NL8603132 A NL 8603132A NL 8603132 A NL8603132 A NL 8603132A NL 8603132 A NL8603132 A NL 8603132A
Authority
NL
Netherlands
Prior art keywords
antibody
iats
pseudomonas aeruginosa
serotypes
fisher
Prior art date
Application number
NL8603132A
Other languages
English (en)
Dutch (nl)
Original Assignee
Genetic Systems Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genetic Systems Corp filed Critical Genetic Systems Corp
Publication of NL8603132A publication Critical patent/NL8603132A/nl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
    • C07K16/1214—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Pseudomonadaceae (F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/808—Materials and products related to genetic engineering or hybrid or fused cell technology, e.g. hybridoma, monoclonal products
    • Y10S530/809—Fused cells, e.g. hybridoma

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
NL8603132A 1985-12-10 1986-12-09 Monoklonale antilichamen kruis-reactief en kruis-beschermend tegen p. aeruginosa serotypen. NL8603132A (nl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US80739485A 1985-12-10 1985-12-10
US80739485 1985-12-10
US93117986A 1986-11-24 1986-11-24
US93117986 1986-11-24

Publications (1)

Publication Number Publication Date
NL8603132A true NL8603132A (nl) 1987-07-01

Family

ID=27123006

Family Applications (1)

Application Number Title Priority Date Filing Date
NL8603132A NL8603132A (nl) 1985-12-10 1986-12-09 Monoklonale antilichamen kruis-reactief en kruis-beschermend tegen p. aeruginosa serotypen.

Country Status (21)

Country Link
US (4) US5378812A (sv)
JP (1) JPH07116237B2 (sv)
KR (1) KR910008361B1 (sv)
CN (1) CN86108380A (sv)
AT (1) AT400441B (sv)
BE (1) BE905890A (sv)
CH (1) CH677362A5 (sv)
DE (1) DE3642095C2 (sv)
DK (1) DK594586A (sv)
FI (1) FI86377C (sv)
FR (1) FR2593826B1 (sv)
GB (1) GB2185266B (sv)
HU (1) HUT41836A (sv)
IE (1) IE59741B1 (sv)
IT (1) IT1199735B (sv)
LU (1) LU86711A1 (sv)
NL (1) NL8603132A (sv)
NO (1) NO178718C (sv)
NZ (1) NZ218499A (sv)
PT (1) PT83894B (sv)
SE (1) SE468831B (sv)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL81370A (en) * 1986-02-07 1991-06-30 Genetic Systems Corp Pharmaceutical and diagnostic compositions comprising a plurality of human monoclonal antibodies for the treatment of bacterial diseases,methods for the preparation of the compositions and antibodies and kits containing said compositions
DK172840B1 (da) * 1986-07-03 1999-08-09 Genetic Systems Corp Monoklonale antistoffer mod Pseudomonas aeruginosa flagella, farmaceutiske præparater indeholdende sådanne antistoffer og c
EP0256713A3 (en) * 1986-08-06 1989-02-15 Merck & Co. Inc. Therapeutic human antipseudomonas aeruginosa antibodies
WO1990011350A1 (fr) * 1989-03-20 1990-10-04 Mitsui Toatsu Chemicals, Inc. Anticorps monoclonal humain reagissant avec le pseudomonas aeruginosa, cellule produisant cet anticorps, procede de production et preparation pharmaceutique
US5521085A (en) * 1986-12-15 1996-05-28 Mitsui Toatsu Chemicals, Inc. Transformed cell lines producing human monoclonal antibodies specific for Pseudomonas aeruginosa serotypes
JP2725041B2 (ja) * 1986-12-15 1998-03-09 三井東圧化学株式会社 ヒトモノクローナル抗体とそれを有効成分とする感染症の予防、治療剤
JPH01197500A (ja) * 1988-01-29 1989-08-09 Sumitomo Chem Co Ltd ヒトモノクローナル抗体
GB2218703B (en) * 1988-05-10 1992-10-28 Sumitomo Chemical Co Human monoclonal antibody to p.aeruginosa: its production and use
CA1341375C (en) * 1988-10-12 2002-07-09 Baxter International Inc. Compositions and methods for the treatment and prevention of gram-negative bacterial infections
EP0382031A3 (en) * 1989-02-10 1991-06-26 Miles Inc. Monoclonal antibodies in immune serum globulin
US4994269A (en) * 1989-03-17 1991-02-19 Miles Inc. Topical use of antibodies for prevention or treatment of pseudomonas infections
JPH02283294A (ja) * 1989-04-24 1990-11-20 Sumitomo Chem Co Ltd ヒトモノクローナル抗体
WO1990013660A2 (en) * 1989-05-09 1990-11-15 Cetus Corporation Human monoclonal antibodies to sero-specific determinants of gram-negative bacteria
US5858728A (en) * 1991-03-13 1999-01-12 Common Services Agency Monoclonal antibody against LPS core
US20030096315A1 (en) 2000-05-03 2003-05-22 Sanders Mitchell C. Device for detecting bacterial contamination and method of use
WO2003063693A2 (en) * 2002-01-31 2003-08-07 Expressive Constructs, Inc. Method for detecting microorganisms
WO2003102142A2 (en) * 2002-05-29 2003-12-11 Henry M. Jackson Foundation For The Advancement Of Military Medicine Inc. Arrays identifying genomic and proteomic biomarkers for cystic fibrosis
ATE544354T1 (de) * 2002-11-26 2012-02-15 Univ Chicago Vermeidung und behandlung von mikrobenübertragenen epithelerkrankungen
CA2514938A1 (en) * 2003-01-31 2004-10-14 Ethicon, Inc. Method for detecting escherichia coli
CA2557612C (en) 2003-11-03 2014-06-17 Ethicon, Inc. Methods, peptides and biosensors useful for detecting a broad spectrum of bacteria
EP1690875A1 (en) * 2005-02-14 2006-08-16 Kenta Biotech AG Human monoclonal antibody specific for lipopolysaccharides (LPS) of the pseudomonas aeruginosa IATS O11 serotype
CA2956427C (en) * 2006-05-01 2021-08-17 Bioness Neuromodulation Ltd. Improved functional electrical stimulation systems
EP2393515A1 (en) * 2009-02-04 2011-12-14 Kalobios Pharmaceuticals, Inc. Combination antibiotic and antibody therapy for the treatment of pseudomonas aeruginosa infection
CA2790289A1 (en) * 2010-02-18 2011-08-25 Meiji Seika Pharma Co., Ltd. Antibody against serotype b lipopolysaccharide of pseudomonas aeruginosa
US10973908B1 (en) 2020-05-14 2021-04-13 David Gordon Bermudes Expression of SARS-CoV-2 spike protein receptor binding domain in attenuated salmonella as a vaccine

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH652145A5 (de) * 1982-01-22 1985-10-31 Sandoz Ag Verfahren zur in vitro-herstellung von hybridomen welche humane monoklonale antikoerper erzeugen.
US4464465A (en) * 1982-04-05 1984-08-07 Genetic Systems Corporation Cell-driven viral transfer in eukaryotes
JPS59137497A (ja) * 1983-01-20 1984-08-07 ザ・リ−ジエンツ・オブ・ザ・ユニバ−シテイ・オブ・カリフオルニア 抗原特異的免疫グロブリン生産性ヒト／ヒトハイブリド−マ及びその生産する抗体
JPS58216125A (ja) * 1982-06-09 1983-12-15 Asahi Chem Ind Co Ltd ヒト抗体の産生方法
JPS5929622A (ja) * 1982-08-10 1984-02-16 Meiji Seika Kaisha Ltd モノクロ−ナル抗体、その製造法およびその用途
EP0151128B1 (en) * 1983-05-06 1991-07-03 Velos Group Monoclonal antibodies reactive with endotoxin core
US4587121A (en) * 1983-06-14 1986-05-06 Miles Laboratories, Inc. High titer Pseudomonas immune serum globulin
US5179018A (en) * 1983-10-14 1993-01-12 Centocor, Inc. Mamalian monoclonal antibodies against endotoxin of gram-negative bacteria
EP0168422A1 (en) * 1983-12-12 1986-01-22 Meru, Inc. Method and materials for the identification of lipopolysaccharide producing microorganisms
US4683196A (en) * 1983-12-12 1987-07-28 Meru, Inc. Method and materials for the identification of lipopolysaccharide producing microorganisms
JPS60248625A (ja) * 1984-05-25 1985-12-09 Mitsui Toatsu Chem Inc 抗緑膿菌モノクロ−ナル抗体、その製法ならびに用途
JP2565303B2 (ja) * 1984-05-25 1996-12-18 三井東圧化学株式会社 緑膿菌感染症の予防治療剤
US4834975A (en) * 1984-05-25 1989-05-30 Genetics Corporation Human monoclonal antibodies to serotypic lipopolysaccharide determinants on gram-negative bacteria and their production
DE3426903A1 (de) * 1984-07-20 1986-01-23 Biotest Pharma GmbH, 6000 Frankfurt Eine immunglobulinpraeparation in kombination mit einer anderen pharmakologisch wirksamen praeparation zur verwendung bei der behandlung von krankheiten
EP0233289B1 (en) * 1984-12-26 1993-03-10 Teijin Limited Hybridomas producing anti-pseudomonas aeruginosa human monoclonal antibody
US4677070A (en) * 1985-04-26 1987-06-30 Cetus Corporation Pseudomonas aeruginosa exotoxin A antibodies, their preparation and use
JPS6229175A (ja) * 1985-07-29 1987-02-07 Nippon Telegr & Teleph Corp <Ntt> 電界効果型トランジスタの製造方法
EP0211352B1 (en) * 1985-08-01 1994-03-16 Miles Inc. Protective antibodies to serotypic determinants of flagellar antigens
US4772464A (en) * 1985-08-01 1988-09-20 Miles Laboratories, Inc. Protective antibodies to serotypic determinants of flagellar antigens
US4777136A (en) * 1985-09-27 1988-10-11 The Regents Of The University Of California Monoclonal antibody reactive with Pseudomonas Aeruginosa
US4970070A (en) * 1986-02-07 1990-11-13 Genetic Systems Corporation Protective monoclonal antibody compositions for infections due to group B streptococcus
DK172840B1 (da) * 1986-07-03 1999-08-09 Genetic Systems Corp Monoklonale antistoffer mod Pseudomonas aeruginosa flagella, farmaceutiske præparater indeholdende sådanne antistoffer og c
EP0256713A3 (en) * 1986-08-06 1989-02-15 Merck & Co. Inc. Therapeutic human antipseudomonas aeruginosa antibodies

Also Published As

Publication number Publication date
NZ218499A (en) 1990-04-26
US5628996A (en) 1997-05-13
US5627067A (en) 1997-05-06
FI86377C (sv) 1992-08-25
CH677362A5 (sv) 1991-05-15
SE468831B (sv) 1993-03-29
GB8629540D0 (en) 1987-01-21
PT83894A (en) 1987-01-01
FI865027A0 (fi) 1986-12-10
SE8605295L (sv) 1987-06-11
SE8605295D0 (sv) 1986-12-10
FI86377B (fi) 1992-05-15
CN86108380A (zh) 1987-10-28
KR910008361B1 (ko) 1991-10-12
FR2593826B1 (fr) 1990-11-16
FI865027A (fi) 1987-06-11
NO178718C (no) 1996-05-22
US5378812A (en) 1995-01-03
NO864971D0 (no) 1986-12-10
GB2185266A (en) 1987-07-15
GB2185266B (en) 1990-09-05
IE59741B1 (en) 1994-03-23
KR870005648A (ko) 1987-07-06
US5662905A (en) 1997-09-02
PT83894B (pt) 1989-07-31
IT1199735B (it) 1988-12-30
NO864971L (no) 1987-06-11
BE905890A (fr) 1987-06-10
IT8622630A0 (it) 1986-12-10
DK594586A (da) 1987-06-11
DE3642095C2 (de) 1998-10-01
JPS62187417A (ja) 1987-08-15
JPH07116237B2 (ja) 1995-12-13
DE3642095A1 (de) 1987-07-02
LU86711A1 (fr) 1988-07-14
DK594586D0 (da) 1986-12-10
AT400441B (de) 1995-12-27
IE863230L (en) 1987-06-10
ATA328286A (de) 1995-05-15
FR2593826A1 (fr) 1987-08-07
NO178718B (no) 1996-02-12
HUT41836A (en) 1987-05-28

Similar Documents

Publication Publication Date Title
NL8603132A (nl) Monoklonale antilichamen kruis-reactief en kruis-beschermend tegen p. aeruginosa serotypen.
US4689299A (en) Human monoclonal antibodies against bacterial toxins
EP0105804B1 (en) Human monoclonal antibodies against bacterial toxins
FI111336B (sv) Förfarande för framställning av ett vaccin som innehåller en polysackaridantigen av typ I av Staphylococcus epidermis och ett hyperimmunoglobulin mot antigenen
JPH02283294A (ja) ヒトモノクローナル抗体
US4834976A (en) Monoclonal antibodies to pseudomonas aeruginosa flagella
JP2645343B2 (ja) 交差防御性ヒト単クローン性抗体またはその結合フラグメントを含む医薬組成物
NL194961C (nl) Compositie omvattende een component die in staat is tot reactie met Pseudomonas aeruginosa flagella, farmaceutisch preparaat, cellijn, monoklonaal antilichaam, werkwijze ter bepaling van Pseudomonas aeruginosa, alsmede pakket voor het detecteren daarvan.
JPS63500035A (ja) プソイドモナス　アエルギノサ　外毒素ａに対する保護用ヒトモノクロ−ナル抗体
JP2587770B2 (ja) 形質転換細胞
JPH02299594A (ja) ヒトモノクローナル抗体およびその製法

Legal Events

Date Code Title Description
BA A request for search or an international-type search has been filed
BB A search report has been drawn up
BC A request for examination has been filed
BN A decision not to publish the application has become irrevocable